Patlytics Attending the 44th Annual J.P. Morgan Healthcare Conference

From January 12–15, 2026, Patlytics will be in San Francisco for the 44th Annual J.P. Morgan Healthcare Conference, the premier global gathering for healthcare and life sciences leaders, investors, and innovators.

Often described as one of the most influential healthcare investment conference in the world, JPM brings together established biopharma companies, emerging biotechnology firms, medical device leaders, and the investment community shaping the future of healthcare. This year’s conversations are expected to focus heavily on innovation, capital allocation, and the responsible application of AI across the healthcare ecosystem.

Why We’re Attending

Life sciences organizations are under increasing pressure to make faster, more confident IP and R&D decisions, often with incomplete information and compressed timelines. At Patlytics, we can work with biotech, pharma, and medical device teams to modernize how patent intelligence supports:

• Early-stage research and competitive landscaping
• Portfolio strategy and diligence
• Litigation risk assessment and enforcement planning
• Executive-level decision-making across R&D, legal, and strategy teams

Our AI-native platform is purpose-built for the complexity of life sciences IP, helping teams move from fragmented patent research to clear, defensible insights. Without sacrificing rigor or data quality.

Let’s Connect in San Francisco

While in San Francisco, you can connect with Andrew Riley from the Patlytics team.

Andrew brings over 15 years of experience across the pharmaceutical and life sciences landscape, with deep expertise in intellectual property strategy, commercial agreements, regulatory considerations, and partnering. His background spans working closely with R&D teams, sponsoring clinical trials, and advising on complex IP and regulatory decisions that directly impact business outcomes.

Andrew enjoys connecting with fellow life sciences leaders to discuss how thoughtful patent intelligence and AI-driven insights can support smarter strategy and execution across the product lifecycle.